查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球外導管市場-2022-2029
市場調查報告書
商品編碼
1140746

全球外導管市場-2022-2029

Global External Catheter Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 170 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

由於尿失禁增加，對外部導管的需求增加

尿失禁是尿液的意外排出。它是由尿道括約肌的控制減少或減弱引起的。它可能發生在壓力源（如咳嗽）期間、母乳喂養期間或之後，並且在肥胖等情況下更為常見。根據美國泌尿學協會的數據，美國有一半到三分之一的男性和女性患有尿失禁。此外，尿失禁影響全球約 2 億人。根據疾病控制和預防中心的數據，美國大約 75% 的醫院獲得性尿石與導尿管相連。根據美國泌尿外科協會的報告，美國四分之一到三分之一的男性和女性患有尿失禁。大約 3300 萬人患有膀胱過度活動症 (OAB)，其特點是尿急、尿頻和急迫性尿失禁。 OAB 是一種尿失禁，也稱為“急迫性”尿失禁。 OAB 是一種威脅生命的疾病，在美國影響超過 30% 的男性和 40% 的女性。

在預測期內，由於全球對微創手術和設備的需求不斷增加，以及公眾意識和可負擔性高，尤其是在新興經濟體，男性體外導管市場將增長。預計將被拖走。此外，慢性病、心血管疾病、泌尿系統疾病和糖尿病的患病率上升，正在增加整個醫療保健行業對導管的需求。

然而，體外導管的洩漏問題阻礙了市場的增長。體外導管經常使用，因此會洩漏。這就是為什麼醫生和醫療保健專業人員更喜歡間歇性導管等選項的原因。與使用外部導管相關的並發症是預計在預測期內抑制全球市場增長的關鍵因素。

地理滲透。

北美將是預測期內的主要地區。

該研究按地區分析了全球市場的外部導管市場，包括北美、歐洲、亞太地區、南美、中東和非洲。

北美將在 2021 年主導全球外部導管市場。在北美，預計美國在預測期內將出現大幅增長。該國完善的醫療保健基礎設施和高昂的人均醫療費用為外部導管創造了巨大的市場。據估計，美國每 6 名男性中就有 1 名出現某種形式的尿失禁。這增加了對導管的需求並推動了市場增長。

預計亞太地區在預測期內的價值也將出現顯著增長。預計對研發和先進產品開發的大量投資將推動該地區的市場增長。由於人口眾多，主要在印度和中國，預計亞太地區外部導管市場在預測期內將出現快速增長。

競爭格局。

由於主要醫療公司的存在，外部導管市場是一個競爭激烈的市場。對全球市場增長做出貢獻的主要公司有 B. Braun Melsungen AG、ConvaTec Healthcare B S.a.r.l、Coloplast Ltd.、Cook Medical、Teleflex Incorporated、Medline Industries Inc、Medtronic、C. R. Bard Inc、Adapta Medical、Becton Dickson Company 等。主要參與者正在為外部導管市場的全球增長採用新產品發布和擴張戰略。 2020 年 9 月，巴德以 30 毫米的價格收購了一家名為 PureWick 的女性外置導管公司。該交易包括產品消耗品和中央供應。 2021年9月，B.Braun Melsungen AG完成對Sterinova Inc.的收購，獲得100%的股權。 Sterinova Inc. 繼續作為 B.Braun Melsungen AG 的獨立子公司運營。 2020 年 11 月，世界領先的醫療器械和藥品製造商之一 B.Braun Melsungen AG 和世界領先的血漿衍生藥物製造商之一併為醫院、診所和藥房中心提供技術和服務的 Grifols 宣布他們將建立藥房業務。宣布全球擴張以提高產量和治療安全性。兩家公司都為安全的藥物輸送提供自動化解決方案。兩家公司將專注於歐洲的商機，並逐步在其他市場推出聯合服務。

COVID-19 的影響。全球外置導管市場穩定增長

由於非 COVID-19 相關的醫療保健設施以正常速度運行，預計全球對外部導管的需求增長將在整個 COVID-19 流行期間保持穩定。在當前的 COVID-19 大流行之後，預計外部導管市場將保持穩定。市場進入者被要求專注於解決 COVID-19 大流行帶來的供應鏈挑戰並設計適當的解決方案。

全球外置導管市場報告包含大約 61 個市場數據表、52 個圖表和 170 頁

內容

第 1 章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

  • 按類型劃分的市場細分
  • 按應用劃分的市場細分
  • 最終用戶的市場細分
  • 按地區劃分的市場細分

第 4 章市場動態

  • 市場影響因素
    • 促進因素
      • 尿失禁增加
      • 慢性病增加
    • 抑制因素
      • 體外導管洩漏問題
    • 影響分析

第 5 章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 價值鏈分析
  • PEST 分析
  • 定價分析
  • 監管分析
  • 保險報銷分析
  • 未滿足的需求
  • 專利趨勢

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按類型

  • 一次性
  • 可反複使用

第 8 章按應用程序

  • 尿失禁
  • 精神疾病
  • 膀胱癌、前列腺癌
  • 其他

第 9 章最終用戶

  • 醫院
  • 居家護理
  • 其他

第 10 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 11 章競爭格局

  • 競爭場景
  • 市場情況/份額分析
  • 併購分析

第 12 章外部導管市場 - 公司簡介

  • B.Braun Melsungen AG
    • 公司概況
    • 按類型和描述劃分的投資組合
    • 主要亮點
    • 財務摘要
  • ConvaTec Healthcare B S.a.r.l.
  • Coloplast Ltd.
  • Cook Medical
  • Teleflex Incorporated
  • Medline Industries Inc.
  • Medtronic PLC
  • C. R. Bard Inc.
  • Adapta Medical
  • Becton Dickson Company（LIST NOT EXHAUSTIVE）

第 13 章重要注意事項

第 14 章 DataM

簡介目錄
Product Code: DMPH3159

Market Overview

External Catheter Market was valued at USD XX million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of 5.39% during the forecast period (2022-2029).

An external catheter is used in patients who are unable to do so normally to drain urine from the bladder. These catheters are meant to be used for a brief period. These are indicated for conditions such as urinary leakage, incontinence, and other problems with the bladder. Neurogenic bladder diseases, such as spinal cord injury, multiple sclerosis, or spina bifida, as well as non-neurogenic bladder diseases, may cause urinary incontinence. The periodic catheter is placed into the urethra, and urine is gathered into the collection bag with the help of the catheter hose. A catheter should be removed after emptying the bladder. The global external catheter market is projected to increase rapidly as the number of Catheter-associated Urinary Tract Infections, which are mainly correlated with indwelling catheter increases. In cases of urinary incontinence or urine leakage, external catheters are always the first option for patients who choose self-catheterization.

Market Dynamics: The rise in prevalence of urinary incontinence increase the demand for external catheter

The accidental discharge of urine is urinary incontinence. The control of the urinary sphincter is either reduced or weakened. It may develop as a result of stress factors like coughing and during and after breastfeeding and is more common in conditions like obesity. According to the American Urological Association, one-half to one-third of men and women in the United States suffer from urinary incontinence. In addition, urinary incontinence impacts nearly 200 million people worldwide. According to the Centers for Disease Control and Prevention, roughly 75% of UTIs obtained in the hospital were connected to a urinary catheter in the United States. According to the American Urology Association report, a quarter to a third of men and women in the U.S. suffer from urinary incontinence. About 33 million have overactive bladder (OAB), representing symptoms of urgency, frequency and with or without urge incontinence. OAB is a type of urinary incontinence, also called "urgency" incontinence. OAB affects more than 30% of men and 40% of women in the U.S. It adversely affects human life.

During the forecast era, the male external catheter market is expected to be driven by increasing demand for minimally invasive procedures and devices worldwide, as well as high awareness and affordability among people, especially in developing economies. Moreover, the rising prevalence of chronic illnesses, cardiovascular and urological conditions, and diabetes has increased catheter demand across the healthcare industry.

However, the leakage issue of the external catheter hampers the market growth. The frequent use of external catheters leads to leakages. As a result, doctors and health care providers favour choices such as intermittent catheters. The complications associated with using external catheters are a key factor expected to curtail the growth of the global market over the forecast period.

Market Segmentation: The disposable segment is projected to be the dominant segment in the market during the forecast period.

Based on the type, the external catheter market has been classified into disposable and repeatable.

The disposables segment dominated the global market in 2021, owing to the wide usage in hospitals where the demand per patient is temporary, and disposable catheters are designed to be thrown away after 24 hours. With patients having limited time in the hospitals, the disposable segment is bound to grow during the forecast period. Whereas the repeatable external catheter is expected to present considerable growth in the near future.

The global external catheter is segmented based on end-user, which includes hospitals, home care and others.

The hospital's segment held a significant market share during the forecast period, as most urinary incontinence and urinary infection cases are brought directly into the hospitals for treatment, supporting the segment growth during the forecast period. Moreover, home care is expected to project a considerable CAGR during the forecast period. Increasing investment in research and product development is expected to propel segment growth in the near future.

Geographical Penetration: North America is the dominating region during the forecast period.

Based on geography, the study analyzes the External Catheter market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North America is holding a dominant position in the global external catheter market in 2021. In North America, the U.S. is expected to represent considerable growth during the forecast period. Well-established healthcare infrastructure and high healthcare expenditure per capita in the country results in a huge market for external catheter. Almost one out of every six men across the United States experiences some urinary incontinence. This increase the need for the catheter, which helps to drive market growth.

Moreover, Asia Pacific is expected to represent significant growth in terms of value during the forecast period. Significant investment in R&D and advanced product development is expected to propel regional market growth. The external catheter market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by the large population base, especially in India and China.

Competitive Landscape:

The external catheter market is highly competitive, owing to the presence of big medical companies. The key players which are contributing to the growth of the global market include B. Braun Melsungen AG, ConvaTec Healthcare B S.a.r.l, Coloplast Ltd.., Cook Medical., Teleflex Incorporated., Medline Industries Inc., Medtronic, C. R. Bard Inc, Adapta Medical, Becton Dickson Company, among others. The major players are adopting new product launch and expansion strategies for global growth in the external catheter market. In September 2020, Bard acquired female external catheter company named as PureWick for $30mm. This deals includes consumables and central supplies of the product. In September 2021, B.Braun Melsungen AG completed acquisition of Sterinova Inc. and owns 100% of the company. Sterinova Inc. continuously operated as a distinct subsidiary of B. Braun Melsungen AG. In November 2020, B.Braun Melsungen AG, one of the world's leading manufacturers of medical devices and pharmaceutical products and services and Grifols, a leading global producer of plasma-derived medicines and provider of technologies and services for hospitals, clinics and compounding centers announced global to enhance pharmacy production output and therapy safety. Together they find solutions for safe automated drug admixture and delivery. They focused on opportunities in Europe and gradually roll out the joint offering in other markets.

COVID-19 Impact: Stable growth on the global external catheter market.

The growth of the global demand for the external catheter is projected to stay stable throughout the emergence of the COVID-19 pandemic, as non-COVID-related healthcare facilities continue to run at a regular pace. The market for the external catheter is expected to stay stable in the wake of the current COVID-19 pandemic. Market participants are required to concentrate on solving the supply chain issues raised by the COVID-19 pandemic and designing appropriate solutions to resolve them.

The global external catheter market report would provide an access to approximately 61 market data tables, 52 figures and 170 pages

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by End User
  • 3.4. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in Urinary Incontinence
      • 4.1.1.2. Increasing prevalence of Chronic diseases
    • 4.1.2. Restraints:
      • 4.1.2.1. Leakage issues in External Catheters
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
  • 7.3. Market Attractiveness Index, By Type Segment
    • 7.3.1. Disposable*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Repeatable

8. By Application

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 8.3. Market Attractiveness Index, By Application Segment
    • 8.3.1. Urinary Incontinence*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Mental illness
    • 8.3.3. Bladder and Prostate Cancer
    • 8.3.4. Others

9. By End User

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
  • 9.3. Market Attractiveness Index, By End User Segment
    • 9.3.1. Hospitals*
      • 9.3.1.1. Introduction
      • 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 9.3.2. Home Care
    • 9.3.3. Others

10. By Region

  • 10.1. Introduction
  • 10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 10.3. Market Attractiveness Index, By Region
  • 10.4. North America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. U.S.
      • 10.4.6.2. Canada
      • 10.4.6.3. Mexico
  • 10.5. Europe
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. Germany
      • 10.5.6.2. U.K.
      • 10.5.6.3. France
      • 10.5.6.4. Italy
      • 10.5.6.5. Spain
      • 10.5.6.6. Rest of Europe
  • 10.6. South America
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.6.6.1. Brazil
      • 10.6.6.2. Argentina
      • 10.6.6.3. Rest of South America
  • 10.7. Asia Pacific
    • 10.7.1. Introduction
    • 10.7.2. Key Region-Specific Dynamics
    • 10.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.7.6.1. China
      • 10.7.6.2. India
      • 10.7.6.3. Japan
      • 10.7.6.4. Australia
      • 10.7.6.5. Rest of Asia Pacific
  • 10.8. Middle East and Africa
    • 10.8.1. Introduction
    • 10.8.2. Key Region-Specific Dynamics
    • 10.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. External Catheter Market- Company Profiles

  • 12.1. B. Braun Melsungen AG*
    • 12.1.1. Company Overview
    • 12.1.2. Type Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. ConvaTec Healthcare B S.a.r.l.
  • 12.3. Coloplast Ltd.
  • 12.4. Cook Medical
  • 12.5. Teleflex Incorporated
  • 12.6. Medline Industries Inc.
  • 12.7. Medtronic PLC
  • 12.8. C. R. Bard Inc.
  • 12.9. Adapta Medical
  • 12.10. Becton Dickson Company (LIST NOT EXHAUSTIVE)

13. Premium Insights

14. DataM Intelligence Analysis

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us